Skip to content

Correlation Between Pelvic Floor Ultrasonographic Features and Pain Severity in Men with Chronic Pelvic Pain Syndrome

Correlation Between Pelvic Floor Ultrasonographic Features and Pain Severity in Men with Chronic Pelvic Pain Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127927
Enrollment
Unknown
Registered
2026-07-10
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pelvic Pain Syndrome

Interventions

Chronic Pelvic Pain Syndrome group:None
Healthy control group:None

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for subjects with chronic pelvic pain syndrome (CPPS):; 1.Adult males aged 18–65 years; 2.Meet the National Institutes of Health (NIH) diagnostic criteria for chronic pelvic pain syndrome (CPPS) , with recurrent (more than once per week) pain in the genital, perineal, suprapubic, or anal region for at least the past 6 months, and the pain cannot be explained by another medical diagnosis; 3.Presence of pelvic floor muscle trigger points, tension bands, or obvious tenderness confirmed by rectal examination; 4.Visual Analogue Scale (VAS) score >= 3; 5.Able to cooperate with examinations and sign informed consent; Inclusion criteria for healthy subjects: 1.Adult males aged 18–65 years; 2.No trigger points, tension bands, or obvious tenderness in the pelvic floor muscles confirmed by rectal examination; 3.Self-reported absence of persistent or recurrent pelvic pain (pain locations including the perineum, genitals, suprapubic region, or perianal area); 4.No abnormal urination (e.g., frequency, urgency, dysuria), no abnormal defecation (e.g., chronic constipation, painful defecation), and no sexual dysfunction (self-assessment of normal erectile and ejaculatory function); 5.Ability to correctly perform pelvic floor muscle contraction and Valsalva maneuver, and to independently complete all questionnaire assessments; 6.No use of any medications that may affect pelvic floor muscle tone or pain perception (e.g., muscle relaxants, opioids, tricyclic antidepressants, etc.) within 4 weeks prior to enrollment;

Exclusion criteria

Exclusion criteria: Exclusion criteria for subjects with chronic pelvic pain syndrome (CPPS):; 1.Clear alternative etiology (e.g., infection, stones, tumor, interstitial cystitis, inflammatory bowel disease, etc.); 2.History of urogenital surgery; 3.Neurological or musculoskeletal diseases affecting pelvic floor function; 4.Presence of severe anxiety or depression (HADS score above the cut-off, e.g., >= 11); 5.Use of any medications that may affect pelvic floor muscle tone or pain perception (e.g., muscle relaxants, opioids, tricyclic antidepressants, etc.) within 4 weeks prior to enrollment; 6.Inability to perform pelvic floor muscle contraction or Valsalva maneuver; Exclusion criteria for healthy subjects:; 1.History of urogenital surgery; 2.Previous history of definite organic diseases that may cause pelvic pain, such as prostatitis, epididymitis, or varicocele; 3.Low cognitive level that prevents cooperation with questionnaire assessments; 4.Presence of severe anxiety or depression (HADS score above the cut-off, e.g., >= 11);

Design outcomes

Primary

MeasureTime frame
Levator plate angle;Anorectal angle;

Secondary

MeasureTime frame
Scoring of clinical symptom and psychological state scales;Displacement of pelvic floor structures;

Countries

China

Contacts

Public ContactLiu Yiming

Peking University People's Hospital

liuyiming1984@163.com+86 10 88325206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026